Prior studies of intestinal adaptation following massive small bowel resection (SBR) have focused on growth factors and their effects on amplification of the gut mucosa. Since adaptive changes have also been described in intestinal smooth muscle, we sought to determine the effect of targeted smooth muscle growth factor overexpression on resection-induced intestinal adaptation. Male transgenic mice with smooth muscle cell overexpression of insulin-like growth factor-I (IGF-1) by virtue of an α-smooth muscle actin promoter were obtained. SMP8 IGF-1 transgenic (IGF-1 TG) and non-transgenic littermates (NT) underwent 50% proximal SBR or sham operation and were then sacrificed after 3 or 28 days. NT mice showed the expected alterations in mucosal adaptive parameters after SBR such as increased wet weight and villus height. The IGF -I TG mice had inherently taller villi, which did not increase significantly after SBR. In addition, IGF-1 TG mice had a 50% postresection persistent increase in remnant intestinal length, which was associated with an early decline and later increase in relative mucosal surface area. These results indicate that growth factor overexpression within the muscularis layer of the bowel wall induces significant postresection adaptive intestinal lengthening and a unique mucosal response. IGF-1 signaling within the muscle wall may play an important role in the pathogenesis of resection-induced adaptation.
INTRODUCTION
Following massive small bowel resection (SBR), there is a vital response that occurs within the remnant intestine termed adaptation. Adaptation predominantly reflects a mitogenic signal acting to enhance cell turnover as characterized by increased rates of both proliferation (33; 34) and apoptosis (11; 28) of enterocytes. As a result, crypts are deeper, villi are taller, and the caliber and length of the intestine increases. These morphologic alterations serve to enhance mucosal digestive and absorptive surface area, thereby compensating for the resected intestine.
Growth hormone (GH) is one of several hormones and growth factors that have been demonstrated to enhance the adaptive response of the small bowel to massive intestinal resection (3; 22) . The trophic effects of GH are largely mediated via the insulinlike growth factor (IGF) family (24) . This family is likely involved in the genesis of the postresection intestinal adaptation response since elevated circulating levels of the IGF binding proteins have been recorded and the expression of type 1 and type 2 IGF receptors are increased in the remnant small bowel (9; 17) . In addition, exogenous administration of IGF-1 has been shown to augment several morphologic and functional parameters of postresection intestinal adaptation (15; 29; 37) .
While the resection-induced adaptation response has classically been acknowledged to involve all layers of the intestinal wall (7; 33), the bulk of research has primarily focused on morphologic and functional alterations within the mucosa.
However, hyperplasia of the muscular layers of the bowel wall has also been described following intestinal resection (16; 19) . The significance of these muscular changes is presently not well understood, but may serve to influence postresection intestinal motility, thereby affecting the capacity for luminal absorption and/or digestion. In addition, muscular hyperplasia and/or hypertrophy may play a role in the adaptive increase in length and caliber of the bowel after massive SBR.
Along these lines, laser capture microdissection was used to identify alterations in the expression of a prototypical growth factor receptor (epidermal growth factor receptor; EGFR) within various cellular compartments of the bowel wall following massive enterectomy (14) . In addition to greater post-resection EGFR transcript in the crypt, the greatest increase occurred within the muscular layer of the bowel wall. Taken together, these data support a significant role for growth factor signaling within the smooth muscle cells (SMC) of the bowel wall to promote postresection intestinal growth.
Under normal conditions, IGF-1 is produced within the bowel wall primarily by mesenchymal cells, including -smooth muscle actin positive myofibroblasts and SMCs (10; 35) . In order to characterize the effects of locally expressed IGF-1 in vivo, a novel transgenic mouse line (SMP8 IGF-1 TG) was generated in which IGF-1 is overexpressed by mesenchymal cells under the control of the mouse α-smooth muscle actin promoter (30) . These mice demonstrated IGF-1 transgene expression within smooth muscle layers of several organs including the intestine but maintained normal circulating levels of IGF-1. The trophic effects of IGF-1 in these mice seem to involve both paracrine and autocrine mechanisms, since hyperplasia of both the mucosal epithelium and muscularis layers were observed (32). In the present study, we now utilize SMP8 IGF-1 mice to directly test the effects of smooth muscle-derived growth factor expression on the adaptive response of the intestine to massive SBR.
METHODS
Experimental Design -The protocol for this study was approved by the Children's Hospital Research Foundation Institutional Animal Care and Use Committee (Cincinnati Children's Hospital Medical Center, Cincinnati, OH). Mice were randomized to undergo either a sham operation or 50% proximal small bowel resection as described below.
Animals from all groups (n = 6-8) were sacrificed on the 3rd or 28th postoperative day and parameters of adaptation determined in the remnant ileum as outlined below.
Animals -
The characterization and phenotypic analysis of the SMP8 IGF-1-transgenic mouse has been previously described (30). Briefly, the transgene is composed of a murine smooth muscle α-actin promoter fragment SMP8 cloned upstream of a rat IGF-1 cDNA. The transgene is highly expressed postnatally, uniquely in SMCs, and is released in a paracrine fashion in tissues with an elevated concentration of smooth muscle such as arteries, veins, uterus, bladder, and the muscular compartment of the gastrointestinal tract. For the purposes of this experiment, FVB/N SMP8 IGF-1-transgenic animals were back-crossed into a C57BL/6 background for 7 generations (weight range 25-29 g; Jackson Laboratories, Bar Harbor, ME). The back-crossings were done because we have observed that the FVB/N strain is less tolerant of SBR procedures when compared with C57BL/6 mice (unpublished data). Male mice were used for the current study. The mice were housed in groups of 4 at 21° C on 12-hour day-night cycles (6 AM to 6 PM) and were allowed to acclimate for at least 5 days before experimentation. One day prior to operation, the diet was changed from regular chow to a liquid rodent diet (MicroStabilized Rodent Liquid Diet LAD 101/101A, Purina Mills, St. Louis MO).
Operative Procedure -The murine model for SBR and sham operation has been described by our group previously (12). In short, the mice were anesthetized using a balanced mixture of inhaled 2% isoflurane, oxygen (90%) and carbon dioxide (4%).
Under sterile conditions and with the aid of an operating microscope (6.25X magnification) the ileocecal junction was identified through a midline incision. Water was provided ad libitum for the first 24 hours. Thereafter, the mice from both experimental groups were fed with a liquid diet. Food intake differences between groups of mice in the postoperative period were negligible. Since the postresection increase in intestinal length in the transgenic mice was associated with significantly greater rates of enterocyte proliferation but unaltered villus heights, the effect of resection on mucosal surface area was measured according to a standardized formula ( Figure 8A ) (13) . As expected, the increased enterocyte proliferation and resultant taller villi in the NT mice after SBR resulted in a significant increase in mucosal surface area ( Figure 8B ). In contrast, mucosal surface area was significantly reduced in the remnant ileum in the SMP8 IGF-1 transgenic mice following SBR. With regard to the later postoperative time (28-day), mucosal surface area continued to increase in the NT mice and began to increase also in the SMP8 IGF-1 transgenic mice. The differential response to intestinal resection with regard to intestinal length, smooth muscle thickness, and mucosal surface area between the non-transgenic and transgenic mice is summarized in Table 1 .
DISCUSSION
In the present study, we have characterized the Enterocyte apoptosis was significantly increased in NT mice after SBR and an equivalent increase occurred after resection in the SMP8 IGF-1 transgenic mice. As with proliferation, it is possible that the paracrine effects of IGF-1 in the transgenic mice was insufficient to affect postresection apoptosis. The regulation of enterocyte apoptosis by apoptosis in the jejunum of parenterally-fed rats with intact bowel (5) . Similarly, in transgenic mice with IGF-1 overexpression resulting in elevated serum levels, rates of apoptosis are reduced (31). On the other hand, systemic administration of IGF-1 to rats undergoing small bowel resection did not affect postresection rates of apoptosis (6) . In that study, rates of apoptosis were noted to decrease in the jejunum of parenterally-fed rats at one week following a 70% mid-jejunoileal resection. This is in contrast with other reports in which rates of enterocyte apoptosis are noted to be elevated in the remnant bowel following intestinal resection (11; 27; 28) . These disparate results might be explained on the basis of several factors, including different animals (rats versus mice), magnitude and site of resection, presence of luminal or parenteral nutrient, and time course following SBR. Despite the fact that postresection rates of apoptosis were similar between the SMP8 IGF-1 transgenic and NT mice in the present study, it is interesting that transgenic IGF-1 overexpression (and elevated plasma levels of IGF-1) has been shown to attenuate irradiation-induced enterocyte apoptosis along with reduced abundance of the pro-apoptotic bax protein in the crypt stem cell region (31). These results fit well with the proposed critical role for bax in the pathogenesis of increased postresection apoptosis (25; 26) .
When compared with NT mice, intestinal resection in the transgenic animals was associated with a modest increase in the expression of IGF-1. In prior studies, intestinal resection in rats has been shown to result in either increased IGF-1 mRNA abundance (9; 38) or no change (1). Since intestinal IGF-1 expression has not previously been described after SBR in mice, our findings in the NT mice were not necessarily incongruent. We distinguished between native and transgenic IGF-1 expression and found that the increase was primarily contributed by native IGF-1 in response to SBR.
Postresection intestinal adaptation characteristically involves all layers of the intestinal wall. More specifically, SMC hyperplasia has been well documented following intestinal resection in rats (16; 21) and dogs (19) . Hyperplasia may occur in face of no change in muscle thickness, possibly due to increased caliber (21) 
